Terbinafine transungual solution - Polichem
Alternative Names: ALM-12834; MYCONORMIN; P-3058Latest Information Update: 17 Jan 2025
At a glance
- Originator Polichem
- Developer Medexus Pharmaceuticals; Polichem
- Class Amines; Antifungals; Naphthalenes; Skin disorder therapies; Small molecules
- Mechanism of Action Cell membrane modulators; Squalene monooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Onychomycosis
Most Recent Events
- 16 Jan 2025 Launched for Onychomycosis in Switzerland, Austria (Topical)
- 22 Mar 2023 Medexus Pharmaceuticals enters in agreement with Polichem to commercialize terbinafine in Canada when approved
- 25 Jul 2022 No development reported - Preregistration for Onychomycosis in European Union (Topical) (Polichem pipeline, July 2022)